Careers  |  Sign In  |  Register  |   Twitter

Latest in Infectious Diseases

Reuters reports that an Ebola vaccine trial has been put on hiatus after four patients alleged that they were experiencing joint pains. The vaccine, developed by Merck and NewLink has been tested on fifty nine volunteers to date. Trials on the GlaxoSmithKline Ebola vaccine yielded no serious side effects in...
According to Reuters, patients with the deadly Ebola virus in West Africa could be saved by something as simple as intravenous fluids. Researchers at the London School of Hygiene and Tropical Medicine and Copenhagen University say many patients with the disease aren't dying from the well-known hemorrhaging...
According to Reuters, the experimental Ebola vaccine co-developed by Merck and NewLink did not have any serious side effects in early trials. Since early November, 34 volunteers have been injected with the VSV-EBOV vaccine, with reported side effects limited to mild fever. In addition to Merck and NewLink,...